HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024
Harmony Biosciences Holdings (Nasdaq: HRMY) has announced it will report its third quarter 2024 financial results on Tuesday, October 29, 2024, before the U.S. financial markets open. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results.
To participate in the call, investors can dial (800) 245-3047 (domestic) or (203) 518-9765 (international) and use the passcode HRMYQ324. It is advised to dial in at least 10 minutes before the call starts. A live and replay webcast of the call will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.
Harmony Biosciences Holdings (Nasdaq: HRMY) ha annunciato che presenterà i suoi risultati finanziari del terzo trimestre 2024 il martedì 29 ottobre 2024, prima dell'apertura dei mercati finanziari statunitensi. L'azienda ospiterà una conferenza telefonica e una trasmissione web il 29 ottobre alle 8:30 a.m. ET per discutere i risultati.
Per partecipare alla chiamata, gli investitori possono comporre il numero (800) 245-3047 (nazionale) o (203) 518-9765 (internazionale) e utilizzare il codice di accesso HRMYQ324. Si consiglia di chiamare almeno 10 minuti prima dell'inizio della chiamata. Una trasmissione web in diretta e il replay della chiamata saranno disponibili nella pagina dedicata agli investitori del sito web di Harmony all'indirizzo https://ir.harmonybiosciences.com/.
Harmony Biosciences Holdings (Nasdaq: HRMY) ha anunciado que reportará sus resultados financieros del tercer trimestre de 2024 el martes 29 de octubre de 2024, antes de la apertura de los mercados financieros de EE. UU. La compañía realizará una llamada de conferencia y una transmisión en vivo a las 8:30 a.m. ET del mismo día para discutir los resultados.
Para participar en la llamada, los inversores pueden marcar (800) 245-3047 (nacional) o (203) 518-9765 (internacional) y usar el código de acceso HRMYQ324. Se recomienda marcar al menos 10 minutos antes de que comience la llamada. Una transmisión en vivo y la repetición de la llamada estarán disponibles en la página de inversores del sitio web de Harmony en https://ir.harmonybiosciences.com/.
하모니 바이오사이언스 홀딩스(Nasdaq: HRMY)는 2024년 3분기 재무 결과를 2024년 10월 29일 화요일에 미국 금융 시장이 열리기 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8시 30분 ET에 재무 결과를 논의하기 위한 컨퍼런스 콜과 웹캐스트를 개최할 것입니다.
전화컨퍼런스에 참여하려면 투자자들은 (800) 245-3047 (국내) 또는 (203) 518-9765 (국제)로 전화하여 비밀번호 HRMYQ324를 사용하면 됩니다. 전화가 시작되기 최소 10분 전에 전화를 걸기를 권장합니다. 컨퍼런스 콜의 생중계와 재방송은 하모니의 투자자 페이지에서 https://ir.harmonybiosciences.com/에서 이용할 수 있습니다.
Harmony Biosciences Holdings (Nasdaq: HRMY) a annoncé qu'elle présentera ses résultats financiers pour le troisième trimestre 2024 le mardi 29 octobre 2024, avant l'ouverture des marchés financiers américains. L'entreprise organisera une conférence téléphonique et un webinaire le 29 octobre à 8h30 ET pour discuter des résultats.
Pour participer à l'appel, les investisseurs peuvent composer le (800) 245-3047 (national) ou (203) 518-9765 (international) et utiliser le code d'accès HRMYQ324. Il est conseillé de composer au moins 10 minutes avant le début de l'appel. Un webinaire en direct et une rediffusion de l'appel seront disponibles sur la page investisseurs du site web de Harmony à l'adresse https://ir.harmonybiosciences.com/.
Harmony Biosciences Holdings (Nasdaq: HRMY) hat angekündigt, dass es seine finanziellen Ergebnisse für das dritte Quartal 2024 am Dienstag, den 29. Oktober 2024, vor der Eröffnung der US-Finanzmärkte bekannt geben wird. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und ein Webcast abhalten, um die Ergebnisse zu diskutieren.
Um an dem Anruf teilzunehmen, können Investoren die Nummer (800) 245-3047 (inland) oder (203) 518-9765 (international) wählen und den Zugangscode HRMYQ324 verwenden. Es wird empfohlen, mindestens 10 Minuten vor Beginn des Anrufs anzurufen. Ein Live-Streaming und eine Wiederholung des Anrufs werden auf der Investorenseite der Website von Harmony unter https://ir.harmonybiosciences.com/ verfügbar sein.
- None.
- None.
To participate in the call, please dial (800) 245-3047 (domestic) or (203) 518-9765 (international), and reference passcode HRMYQ324. It is recommended that you dial in at least 10 minutes prior to the call.
The live and replay webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-report-third-quarter-2024-financial-results-on-october-29-2024-302277106.html
SOURCE Harmony Biosciences
FAQ
When will Harmony Biosciences (HRMY) report its Q3 2024 financial results?
What time is Harmony Biosciences' (HRMY) Q3 2024 earnings call scheduled for?
How can investors participate in Harmony Biosciences' (HRMY) Q3 2024 earnings call?
Where can I find the webcast for Harmony Biosciences' (HRMY) Q3 2024 earnings call?
